1. Home
  2. FATE vs SANG Comparison

FATE vs SANG Comparison

Compare FATE & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$3.16

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Logo Sangoma Technologies Corporation

SANG

Sangoma Technologies Corporation

HOLD

Current Price

$4.05

Market Cap

120.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
FATE
SANG
Founded
2007
1984
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
125.6M
120.1M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
FATE
SANG
Price
$3.16
$4.05
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$4.10
N/A
AVG Volume (30 Days)
4.6M
2.7K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
29.88
N/A
EPS
N/A
N/A
Revenue
$6,646,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$3.40
52 Week High
$3.21
$6.46

Technical Indicators

Market Signals
Indicator
FATE
SANG
Relative Strength Index (RSI) 68.67 60.93
Support Level $1.01 $4.03
Resistance Level $3.21 $5.36
Average True Range (ATR) 0.30 0.12
MACD 0.08 0.05
Stochastic Oscillator 92.49 91.23

Price Performance

Historical Comparison
FATE
SANG

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About SANG Sangoma Technologies Corporation

Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.

Share on Social Networks: